Berzosertib
Berzosertib is a small molecule inhibitor that targets the ATR (Ataxia Telangiectasia and Rad3-related) kinase. ATR is a key regulator of the cellular response to DNA damage and replication stress. Berzosertib functions by inhibiting the ATR kinase activity, thereby disrupting the ATR-mediated DNA damage response pathway.
Lab products found in correlation
3 protocols using berzosertib
Quantifying Viable Tumor Cells by MTT Assay
Drug Combination Treatment Protocol
Drug Combination Treatment Protocol
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!